Despite advances in the diagnosis and treatment of osteoporosis in the last ten years, the condition still poses major clinical challenges. Non-adherence to drug therapy is a widespread problem in patients with rheumatic diseases and osteoporosis in particular.
Part of the Oxford Rheumatology Library, this second edition summarizes the latest developments in the management of osteoporosis and includes new chapters covering the clinical role of denosumab and orthopaedic issues in the management of fractures in patients with osteoporosis. This practical pocketbook is an essential resource for trainees and clinicians in rheumatology, endocrinology, and geriatric medicine, as well as general practitioners and paramedical staff involved in osteoporosis care.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Symbols and abbreviations
1 Pathophysiology of osteoporosis
2 Epidemiology of osteoporotic fracture
3 Diagnosis of osteoporosis
4 Osteoporosis risk assessment
5 Fracture liaison services
6 Calcium and vitamin D deficiency and therapy
12 Vertebroplasty and kyphoplasty
13 Physiotherapy approach to osteoporosis
14 Osteoporosis in men
15 Glucocorticoidinduced osteoporosis GIO
16 Osteoporosis and SREs in neoplastic disease
17 Osteoporosis osteodystrophy and CKDMBD in renal disease
18 Premenopausal osteoporosis
19 Osteoporosis in children and adolescents
abnormalities acid activity adults alendronate assessment associated bisphosphonates body bone loss bone mass bone mineral density bone turnover calcium causes changes Chapter clinical common compared considered controlled denosumab disease dose drug effects efficacy elderly et al evaluation evidence exercise factors falls Figure fracture risk function higher hip fracture hormone identify important improve incidence increased increased risk indications individuals intake interventions Journal kidney less levels major mean measured Medical Medicine months mortality occur oestrogen older oral Osteoporosis International osteoporotic fracture pain patients peak placebo population post-menopausal women potential prevention radiographs randomized rates recent recommended reduce references relative renal reported Research risk factors risk of fracture score secondary severe shown significant skeletal spine suggest Table therapy treated treatment trial vertebral fracture vitamin vitamin D